Screener
PTC Therapeutics PTCT Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: PTC Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:32 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001070081-26-000012
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Other liabilities | (2,309) | (458) |
| Deferred revenue | (1,522) | 7,200 |
| Payments on contingent consideration | — | (4,684) |
| Net cash (used in) provided by operating activities | $(59,042) | $870,103 |
| Cash flows from investing activities | ||
| Purchases of fixed assets | $(1,197) | $(1,724) |
| Proceeds from sale of fixed assets | — | 70 |
| Purchases of marketable securities- available for sale | (454,670) | (322,335) |
Item 1. Financial Statements (unaudited)
FAQ
- What is PTC Therapeutics's operating cash flow?
- PTC Therapeutics (PTCT) reported operating cash flow of -$59.04M in Q1 2026.
- How has PTC Therapeutics's operating cash flow changed year-over-year?
- PTC Therapeutics's operating cash flow decreased by 106.8% year-over-year, from $870.1M to -$59.04M.
- What is the long-term trend for PTC Therapeutics's operating cash flow?
- Over 3 years (2021 to 2024), PTC Therapeutics's operating cash flow has grown at a -24.6% compound annual growth rate (CAGR), from -$251.33M to -$107.69M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about PTC Therapeutics's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude